Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Navarixin |
Synonyms | |
Therapy Description |
Navarixin inhibits CXCR1/2, resulting in suppression of neutrophil recruitment and mucus secretion in the lungs (PMID: 17496165). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Navarixin | MK-7123|SCH 527123|PS291822 | CXCR Antagonist 4 | Navarixin inhibits CXCR1/2, resulting in suppression of neutrophil recruitment and mucus secretion in the lungs (PMID: 17496165). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|